International audienceDetection of anaplastic lymphoma kinase (ALK), ROS proto-oncogene 1 (ROS1), and rearranged during transfection (RET) gene rearrangements in lung adenocarcinoma is usually performed by immunohistochemistry (IHC) screening followed by fluorescence in situ hybridization (FISH), which is an expensive and difficult technique. Ligation-dependent reverse transcription polymerase chain reaction (RT-PCR) multiplex technique can detect gene rearrangements using probes specifically hybridized to either side of the break point. PCR products are then sequenced by pyrosequencing or high throughput sequencing in order to identify the two genes involved. The reagent cost is <15 dollars per patient and results are available in 2 days. ...
Rearrangements of anaplastic lymphoma kinase (ALK) gene in non-small cell lung cancer (NSCLC) define...
Background: Gene fusion events resulting from chromosomal rearrangements play an important role in i...
Introduction: The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NS...
Patients with lung cancers harboring an activating anaplastic lymphoma kinase (ALK) rearrangement re...
International audienceTheranostic translocations may be difficult to detect by routine techniques, e...
Introduction:The approved dual-color fluorescence in situ hybridization (FISH) test for the detectio...
The effectiveness of targeted therapies with tyrosine kinase inhibitors in non-small-cell lung cance...
<div><p>Aims</p><p>To compare fluorescence <i>in situ</i> hybridization (FISH), immunohistochemistry...
EML4-ALK is a new driver gene of non-small cell lung cancer and a target of crizotinib. The objectiv...
Data de publicació electrònica: 19-04-2021The effectiveness of targeted therapies with tyrosine kina...
Gene fusion events resulting from chromosomal rearrangements play an important role in initiation of...
Aims Several predictive biomarkers of response to specific inhibitors have become mandatory for the ...
EML4-ALK is a new driver gene of non-small cell lung cancer and a target of crizotinib. The objectiv...
The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NSCLC ranges fro...
Background: ALK rearrangement is documented in 2%-7% of NSCLC, depending on the population studied a...
Rearrangements of anaplastic lymphoma kinase (ALK) gene in non-small cell lung cancer (NSCLC) define...
Background: Gene fusion events resulting from chromosomal rearrangements play an important role in i...
Introduction: The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NS...
Patients with lung cancers harboring an activating anaplastic lymphoma kinase (ALK) rearrangement re...
International audienceTheranostic translocations may be difficult to detect by routine techniques, e...
Introduction:The approved dual-color fluorescence in situ hybridization (FISH) test for the detectio...
The effectiveness of targeted therapies with tyrosine kinase inhibitors in non-small-cell lung cance...
<div><p>Aims</p><p>To compare fluorescence <i>in situ</i> hybridization (FISH), immunohistochemistry...
EML4-ALK is a new driver gene of non-small cell lung cancer and a target of crizotinib. The objectiv...
Data de publicació electrònica: 19-04-2021The effectiveness of targeted therapies with tyrosine kina...
Gene fusion events resulting from chromosomal rearrangements play an important role in initiation of...
Aims Several predictive biomarkers of response to specific inhibitors have become mandatory for the ...
EML4-ALK is a new driver gene of non-small cell lung cancer and a target of crizotinib. The objectiv...
The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NSCLC ranges fro...
Background: ALK rearrangement is documented in 2%-7% of NSCLC, depending on the population studied a...
Rearrangements of anaplastic lymphoma kinase (ALK) gene in non-small cell lung cancer (NSCLC) define...
Background: Gene fusion events resulting from chromosomal rearrangements play an important role in i...
Introduction: The reported prevalence of ALK receptor tyrosine kinase gene (ALK) rearrangement in NS...